Figure 3From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia Efficacy parameters: Results of ABPI & Ankle pressure are shown as mean ± SD and corresponding p values. V1: screening; V4: 1 month; V5: 3 month; V6: 6 month follow – up. Back to article page